SCHEMBL4045148

SCHEMBL4045148

CCN1CCC(CCCNC=O)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADH1B P00325 3/20 0.42
ADH1A P07327 3/20 0.42
ADH7 P40394 3/20 0.42
ADH1C P00326 2/20 0.42
EPHX1 P07099 3/20 0.41
ADH4 P08319 1/20 0.41
GNAO1 P09471 3/20 0.41
GNAI3 P08754 2/20 0.41
GNAI1 P63096 2/20 0.41
HRH3 Q9Y5N1 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HSD11B1 P28845 1/20 0.36
EPHX2 P34913 1/20 0.34
CHRM4 P08173 2/20 0.33
SIGMAR1 Q99720 2/20 0.33
ALDH1A1 P00352 1/20 0.33
CHRM2 P08172 2/20 0.33
CHRM1 P11229 2/20 0.33
BCHE P06276 1/20 0.33
CHRM5 P08912 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3947858 0.90 EPHX1 (0.40) ADH1BADH1AADH7ADH1CEPHX1
SCHEMBL3955898 0.87 GNAO1 (0.48) ADH1BADH1AADH7ADH1CEPHX1
SCHEMBL3947872 0.81 SMN1; SMN2 (0.39) EPHX1GNAO1HRH3SMN1; SMN2HSD11B1
SCHEMBL3949738 0.81 GNAI3 (0.42) GNAO1GNAI3GNAI1CHRM4SIGMAR1
SCHEMBL5651899 0.80
SCHEMBL3950651 0.80 GNAI3 (0.41) GNAO1GNAI3GNAI1HRH3CHRM4
SCHEMBL3933000 0.79 ADH1B (0.53) ADH1BADH1AADH7ADH1CEPHX1
SCHEMBL22856387 0.79 SIGMAR1 (0.48) EPHX1GNAO1HRH3SMN1; SMN2HSD11B1
SCHEMBL31273045 0.78 HRH3 (0.46) EPHX1GNAO1HRH3SMN1; SMN2HSD11B1
SCHEMBL28149564 0.78 HRH3 (0.46) EPHX1GNAO1HRH3SMN1; SMN2HSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009024825-A1 2-PYRAZINYLBENZIMIDAZOLE DERIVATIVES AS RECEPTOR TYROSINE KINASE INHIBITORS ASTRAZENECA AB (SE) 2009-02-26 WO disclosed